The present invention relates to a biocompatible biomaterial, in particular a biocompatible sponge, deriving from protein pastes obtained as by-products of human plasma fractionation, optionally processed in a scaffold of other biomaterials such as collagen, hyaluronic acid, etc. The technology of the invention enables to recycle one or more protein fractions obtained as by-products, which are currently disposed of as industrial waste, thus increasing manufacturing costs. The described method enables to obtain a biomaterial with haemostatic properties. Other possible uses relate to its use as a scaffold for cell cultures in tissue engineering applications.

“Haemostatic biomaterial from waste fractions of human plasma fractionation process”

PAJEWSKI, Leonardo;VEGLIO', FRANCESCO
2009

Abstract

The present invention relates to a biocompatible biomaterial, in particular a biocompatible sponge, deriving from protein pastes obtained as by-products of human plasma fractionation, optionally processed in a scaffold of other biomaterials such as collagen, hyaluronic acid, etc. The technology of the invention enables to recycle one or more protein fractions obtained as by-products, which are currently disposed of as industrial waste, thus increasing manufacturing costs. The described method enables to obtain a biomaterial with haemostatic properties. Other possible uses relate to its use as a scaffold for cell cultures in tissue engineering applications.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11697/29260
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact